Journal
NEUROLOGY
Volume 99, Issue 2, Pages 84-85Publisher
LIPPINCOTT WILLIAMS & WILKINS
DOI: 10.1212/WNL.0000000000200900
Keywords
-
Categories
Ask authors/readers for more resources
The article by Pallud et al. discusses the significant improvement in survival observed in glioma patients with isocitrate dehydrogenase wild-type who received levetiracetam throughout the standard chemoradiation protocol.
We read with interest the article by Pallud et al.(1) in which patients with isocitrate dehydrogenase wild-type glioma who took levetiracetam during the whole standard chemoradiation protocol experienced relevant improvement in survival.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available
Share Paper
